Clinical Trials Browser

Phase 3 × Carcinoma, Non-Small-Cell Lung × lonafarnib × Clear all

NCT00050336 2015-08-27

Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis